好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Poster Session 07

Thursday 04/30/09
07:00 AM - 10:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Sleep, Aging and Dementia, Anterior Horn, Behavioral Neurology, Child Neurology/Developmental Neurobiology, Epilepsy, MS and Related Diseases, Peripheral Nerve
No CME available
Event Timeline
07:00 AM - 08:30 AM Break
07:00 AM - 10:00 AM Abstract 002 - Sudden Unexpected Near Death in Epilepsy (SUNDEP): Malignant Ventricular Arrhythmia from a Partial Seizure
07:00 AM - 10:00 AM Abstract 003 - Levetiracetam Extended Release: Population Dose-Response Modeling in Adults with Partial-Onset Seizures
07:00 AM - 10:00 AM Abstract 004 - Meta-Analysis of Levetiracetam Used in Status Epilepticus
07:00 AM - 10:00 AM Abstract 005 - Patient Abilities and Techniques Used for Seizure Self-Termination
07:00 AM - 10:00 AM Abstract 006 - Carbamazepine and Atherosclerosis: Is There Any Link?
07:00 AM - 10:00 AM Abstract 007 - Visual Field Defects after Transylvian Selective Amygdalohippocampectomy
07:00 AM - 10:00 AM Abstract 008 - Novel Neuroprotective Drugs Against Experimentally Induced Status Epilepticus
07:00 AM - 10:00 AM Abstract 009 - Clinical Characteristics of Alcohol Related Seizures
07:00 AM - 10:00 AM Abstract 010 - Ketogenic Diet Treatment of Intractable Epilepsy
07:00 AM - 10:00 AM Abstract 011 - Effect of Levetiracetam on Testosterone Levels in Male Patients
07:00 AM - 10:00 AM Abstract 012 - Comorbidities in Patients with Psychogenic Nonepileptic Seizures
07:00 AM - 10:00 AM Abstract 013 - A Profile of Adolescent-Onset Epilepsy
07:00 AM - 10:00 AM Abstract 014 - Relationship between Dysautonomia, Clinical Features and Cognitive Dysfunction in Dementia with Lewy Bodies
07:00 AM - 10:00 AM Abstract 015 - Feasibility, Reliability, and Minimal Detectable Change for Maximal Exercise Testing in Mild Alzheimer Disease
07:00 AM - 10:00 AM Abstract 017 - Association Study of Serum Heme Oxigenase-1 Levels with Alzheimer's and Parkinson's Diseases
07:00 AM - 10:00 AM Abstract 018 - Memantine Discontinuation Due to Non-Medical Reasons Is Associated with a Subsequent Decline in Patients' Health Status in Nursing Home Residents with Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 019 - Idiopathic Parkinson's-Like [alpha]-Synucleopathy in TDP-43-Negative FTLD-U with Basophilic Inclusions
07:00 AM - 10:00 AM Abstract 020 - 3-n-Butylphthalide Improves Cognitive Deficits of SAMP8 Mice
07:00 AM - 10:00 AM Abstract 021 - MCP-1 A-2518G Polymorphism: Effect on Susceptibility for Frontotemporal Lobar Degeneration and on Cerebrospinal Fluid MCP-1 Level
07:00 AM - 10:00 AM Abstract 022 - Relevance of CSF Levels of Secreted Amyloid-b Precursor Protein (APP) and Amyloid-[beta] Peptides (A[beta]) in NPH to Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 023 - The Contribution of Apolipoprotein E Alleles on Cognitive Performance and Behavioral Changes in Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 024 - Depression and Somatic Symptoms Determine Quality of Life in Nonepileptic Seizures
07:00 AM - 10:00 AM Abstract 025 - ERP Abnormalities of Auditory Attention in Fragile X-Associated Tremor/Ataxia Syndrome
07:00 AM - 10:00 AM Abstract 026 - Neural Correlates of Successful Attention and Executive Functions Training in MS: An fMRI Study
07:00 AM - 10:00 AM Abstract 027 - Distractibility and Alzheimer Disease: The "Neglected" Phenomenon
07:00 AM - 10:00 AM Abstract 028 - A Restless Dementia Responsive to Carbidopa/Levodopa: A Case Study
07:00 AM - 10:00 AM Abstract 029 - Functional MRI of Dynamic 3D Visual Object Recognition
07:00 AM - 10:00 AM Abstract 030 - Prism Adaptation and Learning Curves in Spatial Neglect
07:00 AM - 10:00 AM Abstract 031 - Dopaminergic Modulation of Degenerative Spatial Neglect Phenomena
07:00 AM - 10:00 AM Abstract 032 - MEANING: Musical Emotion and Affect Naming In NeurodeGeneration - A Pilot Investigation
07:00 AM - 10:00 AM Abstract 033 - Effect of Prism Adaptation on "Aiming" Spatial Bias and Functional Abilities
07:00 AM - 10:00 AM Abstract 034 - Real Time Functional MRI: Next Generational fMRI
07:00 AM - 10:00 AM Abstract 035 - Genetic Association Studies of Immune Genes in Autism
07:00 AM - 10:00 AM Abstract 036 - Magnetic Source Imaging (MSI) Activation of the Mesial Temporal Lobe: Relationship to Wada Memory Performance
07:00 AM - 10:00 AM Abstract 037 - Cognitive and Functional Consequences of Chronic Cerebellar Injury
07:00 AM - 10:00 AM Abstract 038 - Complex Regional Pain Syndrome - A Cluster Analysis of Neuropsychological Deficits
07:00 AM - 10:00 AM Abstract 039 - Neuro-Anatomical Correlates of Visual Memory in Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 040 - Behavioral and Cortical Activation Patterns in Hemianopia
07:00 AM - 10:00 AM Abstract 041 - Age-Related Differences in Efficiency of Working Memory Processing among High vs. Low Performers: When Is Less More?
07:00 AM - 10:00 AM Abstract 042 - Putaminal Volumetrics in Frontotemporal Lobar Degeneration: Manual Tracing Showing Differential Volumes in Subtypes of FTLD
07:00 AM - 10:00 AM Abstract 043 - Noradrenergic Effects on Functional Connectivity in Autism Spectrum Disorder
07:00 AM - 10:00 AM Abstract 044 - Motor Cortex Reward Signaling in Parkinson's Disease
07:00 AM - 10:00 AM Abstract 045 - Altered Auditory Feedback in Stuttering: Preliminary Studies
07:00 AM - 10:00 AM Abstract 046 - Creativity in Parkinson Disease as a Function of Right Versus Left Hemibody Onset
07:00 AM - 10:00 AM Abstract 047 - Decreased Frequency of Severe Arithmetic Learning Disability in Girls with Turner Syndrome Treated with Oxandrolone Versus Placebo
07:00 AM - 10:00 AM Abstract 048 - The Effect of Ejection Fraction and Age on Memory Functioning in Older Adults with Heart Failure
07:00 AM - 10:00 AM Abstract 049 - Effects of Adjunctive Armodafinil on Patients with Schizophrenia
07:00 AM - 10:00 AM Abstract 050 - Seronegative Non-Paraneoplastic Limbic Encephalitis: New Evidence of Autoimmune Pathogenesis
07:00 AM - 10:00 AM Abstract 051 - Gabapentin Enacarbil Improves Sleep in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 052 - Gabapentin Enacarbil Improves Mood, Quality of Life (QOL) and Functioning in Subjects with Primary Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 053 - Gabapentin Enacarbil Relieves the Pain Associated with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 054 - A Randomized, Double-Blind, Placebo-Controlled Study To Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 055 - The Maintenance of Efficacy and Long-Term Tolerability of Gabapentin Enacarbil Compared with Placebo in Subjects with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 056 - Efficacy and Safety of Pramipexole for Restless Legs Syndrome: A 26 Week Randomized, Placebo-Controlled Clinical Trial in the European Union
07:00 AM - 10:00 AM Abstract 057 - Efficacy and Tolerability of Rotigotine in the Treatment of Patients with Most Severe RLS and Augmentation - A 12 Months Clinical Survey
07:00 AM - 10:00 AM Abstract 058 - Augmentation in the Therapy of the Restless Legs Syndrome with Transdermal Rotigotine - A Retrospective Systematic Analysis of Two Large Double-Blind 6-Month Trials
07:00 AM - 10:00 AM Abstract 059 - Frequency of Impulse Control Disorders in Patients with Restless Legs Syndrome Treated with Dopaminergic Agents
07:00 AM - 10:00 AM Abstract 060 - Rotigotine Transdermal System in the Treatment of Idiopathic Restless Legs Syndrome: Combined Results from Two Double-Blind, Placebo-Controlled, Multicenter Studies in Europe and the US
07:00 AM - 10:00 AM Abstract 061 - Error Monitoring Is Impaired in Obstructive Sleep Apnea
07:00 AM - 10:00 AM Abstract 062 - Patients at High Risk for Obstructive Sleep Apnea Identified Using the Berlin Sleep Questionnaire Have Worse Functional Outcomes Following a Stroke
07:00 AM - 10:00 AM Abstract 063 - Association of Periodic Limb Movements without Restless Legs and Cardiovascular Disease
07:00 AM - 10:00 AM Abstract 064 - Developing and Validating a Patient-Reported Post-Sleep Diary for Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 065 - Efficacy, Tolerability, and Compliance of CPAP Therapy for Obstructive Sleep Apnea in Patients with Mild Cognitive Impairment or Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 066 - Clinical Usefulness of Sleep Questionnaires in Patients with Obstructive Sleep Apnea Syndrome
07:00 AM - 10:00 AM Abstract 067 - Prevalence of Restless Legs Syndrome in Patients in Hemodialysis Compared with Peritoneal Dialysis
07:00 AM - 10:00 AM Abstract 068 - Validation of the Post-Sleep Questionnaire (PSQ) for Assessment of Sleep in Subjects with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM Abstract 069 - What Is Quality of Life for Persons with Restless Legs Syndrome?
07:00 AM - 10:00 AM Abstract 070 - Self-Report of Restlessness Is Not Enough: Exclusion of Secondary Causes of RLS in Utah Kindreds and Search for Genetic Linkage to Published Loci
07:00 AM - 10:00 AM Abstract 071 - Motor Planning and Disease Severity Impact Ambulatory Behavior in Parkinson's Disease
07:00 AM - 10:00 AM Abstract 072 - DJ-1 Expression Modulates Astrocyte-Mediated Neuroprotection in a Toxin-Specific Manner
07:00 AM - 10:00 AM Abstract 073 - Oscillatory Activities Recorded from the Human Pedunculopontine Nucleus Region during Voluntary Movements
07:00 AM - 10:00 AM Abstract 074 - DOPAL Treated Rat: A New Behavioral Model for Parkinson's Disease
07:00 AM - 10:00 AM Abstract 075 - Are There Differences in Cerebral White Matter Lesion Burdens between Parkinson's Disease Patients with and without Dementia?
07:00 AM - 10:00 AM Abstract 076 - Metabolic Profiles of the Striatum and the Nucleus Accumbens Detected by Proton Magnetic Resonance Spectroscopy (1H MRS) In Vivo in a Murin Model of Parkinson's Disease, the MPTP-Intoxicated Mouse, before and after Levodopa Administration
07:00 AM - 10:00 AM Abstract 077 - CSF from Parkinson's Disease Patients Differentially Affects [alpha]-Synuclein Density and Cell Growth in Microglia Compared to Astrocytes
07:00 AM - 10:00 AM Abstract 078 - Autophagic Stress: A Key Problem of Autophagy Upregulation
07:00 AM - 10:00 AM Abstract 079 - Abnormal Metabolic Network Activity during Phenoconversion of Preclinical Huntington's Disease
07:00 AM - 10:00 AM Abstract 080 - Recessive Mutations in an Ubiquitin-Like Gene Cause a Late-Onset Recessive Cerebellar Ataxia
07:00 AM - 10:00 AM Abstract 081 - Clinical Efficacy in Focal Dystonia and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins)
07:00 AM - 10:00 AM Abstract 082 - Temporal Discrimination Thresholds in Adult-Onset Primary Torsion Dystonia - Physiological and Structural Imaging Evidence for an Endophenotype
07:00 AM - 10:00 AM Abstract 083 - Long Term Efficacy of Deep Brain Stimulation for Dystonia: A Blinded Assessment
07:00 AM - 10:00 AM Abstract 084 - Sensory Disinhibition in Cervical Dystonia
07:00 AM - 10:00 AM Abstract 085 - Effect of Spasticity on Physical Function and Health of Nursing Home Residents
07:00 AM - 10:00 AM Abstract 086 - Long-Term (7-Year) Cervical Dystonia Safety Study with Botulinum Toxin Type B
07:00 AM - 10:00 AM Abstract 087 - A Profile of Dystonia in Children: Experience from a Pediatric Neurology Center
07:00 AM - 10:00 AM Abstract 088 - Efficacy and Safety of NT 201 (Neurotoxin Free from Complexing Proteins) in Cervical Dystonia
07:00 AM - 10:00 AM Abstract 089 - Long-Term Follow-Up of DYT1 Dystonia Patients Treated by Deep Brain Stimulation
07:00 AM - 10:00 AM Abstract 090 - Levodopa-Induced Dyskinesias in Spinocerebellar Ataxia Type 2
07:00 AM - 10:00 AM Abstract 091 - Efficacy and Safety of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins) in Blepharospasm
07:00 AM - 10:00 AM Abstract 092 - Prognostic Value of Sleep Wake Cycle on Video EEG and MRI in Neonates with HIE Treated with Cool Cap
07:00 AM - 10:00 AM Abstract 093 - Postnatal Period of Intervention of GTA Supplementation Determines the Extent of Phenotypic Improvement in Tremor Rat Model of Canavan Disease
07:00 AM - 10:00 AM Abstract 094 - Age- and Region-Specific Analysis of Monoaminergic Systems in the Brain of Mecp2-Null Mice Implies the Prefrontal and Motor Cortices in the Earliest Stages of Disease
07:00 AM - 10:00 AM Abstract 095 - Cerebral Folate Deficiency and Mitochondrial Disease
07:00 AM - 10:00 AM Abstract 096 - Deep Brain Stimulation in Patients with Dystonic Cerebral Palsy: 6 Month Follow-Up
07:00 AM - 10:00 AM Abstract 097 - Developmental Expression of Synaptic Vesicle Protein SV2A
07:00 AM - 10:00 AM Abstract 098 - Clinical Outcomes in Patients with Duchenne Muscular Dystrophy and Role of Multidisciplinary Care
07:00 AM - 10:00 AM Abstract 099 - Use of Saliva To Monitor Phenobarbital Levels in Neonates: A Pilot Study
07:00 AM - 10:00 AM Abstract 100 - Metabolic and Neurological Complications of Antipsychotic Therapy in Children with Tourette Syndrome
07:00 AM - 10:00 AM Abstract 101 - Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 102 - Ethnicity Is a Possible Risk Factor in the Development of Anti-Epileptic Drug Induced Cutaneous Reactions
07:00 AM - 10:00 AM Abstract 103 - Lateralization of Temporal Lobe Epilepsy with Long-Term Ambulatory Intracranial Monitoring Using the RNS[trade] System
07:00 AM - 10:00 AM Abstract 104 - Voxel Based Morphometry Reveals Differences in Familial and Sporadic Forms of Refractory MTLE
07:00 AM - 10:00 AM Abstract 105 - Safety Profile of Levetiracetam Extended Release as Compared to Immediate Release. An Indirect Comparison Using a Meta-Analytic Approach
07:00 AM - 10:00 AM Abstract 106 - A New Methodology for Predicting Unbound Phenytoin Concentrations in Hypoalbuminemic Patients, a Novel Approach
07:00 AM - 10:00 AM Abstract 107 - Clinical Profile of Epilepsy and the Cost of Its Treatment in a Tertiary Care Center in India
07:00 AM - 10:00 AM Abstract 108 - [3H]Levetiracetam Binding to Brain Membranes: A Putative Allosteric Modulator of AMPA Glutamate Receptor Desensitization
07:00 AM - 10:00 AM Abstract 109 - Cumulative Effect of Vagal Nerve Stimulator in Intractable Seizures Observed over a Period of Three Years
07:00 AM - 10:00 AM Abstract 110 - Prognostic Importance of Risk Factors for Extratemporal Lobe Epilepsy in Patients Undergoing Surgical Treatment
07:00 AM - 10:00 AM Abstract 111 - Suboptimal Dialogue around Mood/Behavior and Side Effects of Epilepsy Medications: Results of an Observational Linguistic Study
07:00 AM - 10:00 AM Abstract 112 - Long-Term Treatment of Partial Epilepsy with Eslicarbazepine Acetate (ESL): Results of a One-Year Open-Label Extension to Study BIA-2093-301
07:00 AM - 10:00 AM Abstract 113 - Radiosurgery for MTLE: Sparing of Neurocognition, Prediction of Seizure Remission, and Potential Antiepileptic Mechanisms of Dose-Related Peak MRI Effects
07:00 AM - 10:00 AM Abstract 114 - Postsurgical Outcome of Frontal Lobe Epilepsy. An Unexpected Finding
07:00 AM - 10:00 AM Abstract 115 - Evaluation of Lacosamide Efficacy in Subjects with Difficult-to-Treat Partial-Onset Seizures across the Dose Range Used in Phase II/III Clinical Trials
07:00 AM - 10:00 AM Abstract 116 - Empiric Use of Polycitra K[reg] with the Ketogenic Diet Reduces Kidney Stone Incidence
07:00 AM - 10:00 AM Abstract 117 - An Evaluation of the Efficacy and Safety of Eslicarbazepine Acetate (ESL) as Add-On Treatment in Adults with Refractory Partial-Onset Seizures: BIA-2093 Study
07:00 AM - 10:00 AM Abstract 118 - Early Onset of Efficacy in the Initial Weeks of Treatment with Lacosamide: A Pooled Analysis of Three Phase II/III Trials
07:00 AM - 10:00 AM Abstract 119 - Clinical Significance of Persistent Fetal PCA in Epilepsy Surgery Candidates
07:00 AM - 10:00 AM Abstract 120 - Catamenial Epilepsy Frequency with Various Antiepileptic Drugs
07:00 AM - 10:00 AM Abstract 121 - Lacosamide Efficacy Is Independent of Concomitant AED(s) Treatment
07:00 AM - 10:00 AM Abstract 122 - Thrombolysis in Stroke Attributable to Extra- or Intracranial Cerebral Artery Dissection - Swiss Survey of IV Thrombolysis
07:00 AM - 10:00 AM Abstract 123 - Outcome of Too Mild Stroke Patients Treated with Thrombolysis: Is It Safe and Effective?
07:00 AM - 10:00 AM Abstract 124 - Barriers to tPA Use for Inpatient Ischemic Strokes
07:00 AM - 10:00 AM Abstract 125 - Comparison of tPA Treatment between NonHispanic White and Hispanic American Stroke Patients
07:00 AM - 10:00 AM Abstract 126 - Implant for Perfusion Augmentation Clinical Trial -1 (ImPACT-1). A Safety and Effectiveness Evaluation of the Ischemic Stroke System (ISS*) in the Treatment of Acute Ischemic Stroke - Pilot Study Report
07:00 AM - 10:00 AM Abstract 127 - Randomized Study of Butylphthalide (NBP) in Treatment of Acute Cerebral Infarction
07:00 AM - 10:00 AM Abstract 128 - tPA Therapy Following Acute Stroke Increases Plasma MMP-9 Activity out to Twenty Four Hours
07:00 AM - 10:00 AM Abstract 129 - Intravenous Recombinant Tissue Plasminogen Activator Administered at 3 to 6 Hours Following Onset of Ischemic Stroke Does Not Improve Outcome. A Meta-Analysis
07:00 AM - 10:00 AM Abstract 130 - Is Estimated Patient Weight Accurate for IV rt-PA Dosing in Acute Stroke?
07:00 AM - 10:00 AM Abstract 131 - tPA by Telephone: Comparison of Telephonic Versus In-House Parallel Treatment for Two Cohorts
07:00 AM - 10:00 AM Abstract 132 - Cutaneous Candida Infection after Treatment with Natalizumab
07:00 AM - 10:00 AM Abstract 133 - HALT MS - Phase II Clinical Trial of High Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Active Relapsing-Remitting Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 134 - Natalizumab Use in Two French Multiple Sclerosis Centers: The Incidence of Hypersensitivity Reactions Based on Premedication Practices
07:00 AM - 10:00 AM Abstract 135 - Comparison of Two Therapeutic Strategies in Active Relapsing-Remitting MS: Cyclophosphamide as Induction for 12 Months Followed by Interferon Beta Versus Interferon Beta. A 2-Year Randomized Trial
07:00 AM - 10:00 AM Abstract 136 - Case Report of Recurrent Pericarditis Due to Natalizumab Treatment with Positive Re-Challenging Test
07:00 AM - 10:00 AM Abstract 137 - Hypereosinophilia under Natalizumab
07:00 AM - 10:00 AM Abstract 138 - Memantine as a Treatment for Spasticity in Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 139 - Enhancement Volumes in Multiple Sclerosis Patients Randomized to Interferon Beta 1b or Glatiramer Acetate Imaged by Monthly 3 Tesla Brain MRI with Triple Dose Gadolinium
07:00 AM - 10:00 AM Abstract 140 - B Cell Depletion and Safety of Low Dose Rituximab in Patients with Relapsing Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 141 - A Phase 1 Trial of Probiotic Helminth Ova in Relapsing Remitting Multiple Sclerosis (RRMS)
07:00 AM - 10:00 AM Abstract 142 - One Year Follow-Up Results from a Phase 2 Trial of the BHT-3009 DNA Vaccine for Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 143 - Two Annual Cycles of Alemtuzumab Yield Durable Treatment Response 24 Months after Last Dose
07:00 AM - 10:00 AM Abstract 144 - High Bioavailability and Long Half-Life of Oral Fingolimod (FTY720), an Investigational Treatment for Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 145 - Efficacy of a New Formulation of Subcutaneous Interferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis: 16-Week Results from a Double-Blind, Placebo-Controlled Study
07:00 AM - 10:00 AM Abstract 146 - 4-Aminopyridine as a Treatment for Intractable Eructation: The First Case Report
07:00 AM - 10:00 AM Abstract 147 - Alemtuzumab Immunotherapy of Treatment-Refractory Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 148 - Efficacy and Tolerability of Pramipexole in Multiple Sclerosis: Treatment for "Rubral Tremor" Related
07:00 AM - 10:00 AM Abstract 149 - Long-Term Efficacy and Safety of Intense Immunosuppression as First Line Therapy in Clinically Active Relapsing MS: A New Treatment Algorithm
07:00 AM - 10:00 AM Abstract 150 - Pharmacokinetic Study of Lipoic Acid in Multiple Sclerosis: Comparing Mice and Human Pharmacokinetic Parameters
07:00 AM - 10:00 AM Abstract 151 - Efficacy and Safety of Natalizumab in Multiple Sclerosis Patients Pretreated with Immunomodulatory and Immunosuppressive Drugs
07:00 AM - 10:00 AM Abstract 152 - Pregbalin for Treating Paroxysmal Painful Symptoms in Multiple Sclerosis: An Open Label Study
07:00 AM - 10:00 AM Abstract 153 - Treating MS Relapses at Home. The Combined Experience of 4 French Regional MS Networks (LORSEP, RBN-SEP, SEP-AUvergne and SINDEFI-SEP) for 807 Patients
07:00 AM - 10:00 AM Abstract 154 - Modifying Therapies Used in Severe First Idiopathic Acute Inflammatory Events within the Central Nervous System
07:00 AM - 10:00 AM Abstract 155 - Mycophenolate Mofetil in Multiple Sclerosis: A Retrospective Study
07:00 AM - 10:00 AM Abstract 156 - Moderate Intensity Resistance Training Does Not Significantly Alter Disease Progression in a Representative Group of ALS Patients
07:00 AM - 10:00 AM Abstract 157 - Safety Profile of Lithium Treatment in Patients with ALS: A Prospective Open-Label and Off-Label Cohort Studies
07:00 AM - 10:00 AM Abstract 158 - Is Lithium Therapy Safe for ALS Patients?
07:00 AM - 10:00 AM Abstract 159 - Retrograde Viral Delivery of GDNF and IGF1 Prevents the Development of Late Weakness (Post-Polio Syndrome) in a Mouse Model
07:00 AM - 10:00 AM Abstract 160 - Minocycline and Verapamil Reduce Riluzole's Effectiveness in a Preclinical Model System of Mechanisms of Sporadic Amyotrophic Lateral Sclerosis (ALS) Pathogenesis
07:00 AM - 10:00 AM Abstract 161 - A Phase I-II Multicenter Study on G-CSF in ALS: Clinical and Haematological Results
07:00 AM - 10:00 AM Abstract 163 - Safety and Short Term Effects of Umbilical Cord Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis: Review of Chinese Data
07:00 AM - 10:00 AM Abstract 164 - A Double-Blind, Placebo-Controlled, Randomized Trial of Growth Hormone as Add-On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: Preliminary MRS, Hormonal, and Population Analysis
07:00 AM - 10:00 AM Abstract 165 - Pontobulbar Palsy with Deafness (Brown-Vialetto-Van Laere Syndrome): Treatment and Prognosis in Ten Patients
07:00 AM - 10:00 AM Abstract 166 - Different Pathologic Features in Neurfilament Light Chain (NEFL) Pro22 Mutation in Charcot-Marie-Tooth Disease
07:00 AM - 10:00 AM Abstract 168 - Sequence Analysis of the [alpha]-Crystallin Type Heat Shock Protein Gene Family in Motor Neuropathy Patients
07:00 AM - 10:00 AM Abstract 169 - CIDP Induced by TNF-[alpha] Antagonists in Rheumatoid Arthritis
07:00 AM - 10:00 AM Abstract 170 - Concomitance of an Inherited and an Acquired Demyelinating Neuropathy in a Young Girl
07:00 AM - 10:00 AM Abstract 171 - De Novo Amyloid Deposits and Induced Polyneuropathy in FAP Domino Liver Recipients
07:00 AM - 10:00 AM Abstract 172 - Parent-of-Origin Effect on Penetrance in Transthyretin Related Familial Amyloid Polyneuropathy
07:00 AM - 10:00 AM Abstract 173 - CMT2A2 with Upper Motor Neuron Signs in a Patient with a Novel De Novo Mutation in MFN2
07:00 AM - 10:00 AM Abstract 174 - The Clinical Spectrum of X-Linked Charcot-Marie-Tooth Disease in Childhood
07:00 AM - 10:00 AM Abstract 175 - Novel Giant Axonal Neuropathy Mutation C[rarr]A146{Ala49Glu} Mimicking Chronic Immune Demyelinating Polyradiculoneuropathy
Faculty Disclosures
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
nobl barazangi, MD, PhD Dr. Barazangi has nothing to disclose.
Jose E. Cavazos, MD, PhD Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Vijay Dhawan, PhD No disclosure on file
No disclosure on file
Jeffrey M. Burns, MD Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Chiara Fenoglio, PhD No disclosure on file
Michael Calloway No disclosure on file
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Mark Decerbo, PharmD No disclosure on file
Andrew G. Herzog, MD, MSc, FAAN Dr. Herzog has nothing to disclose.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Andres M. Kanner, MD, FAAN Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Heather S. Anderson, MD, FAAN No disclosure on file
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
I-Hweii A. Chen, MD, PhD, FAAN The institution of Dr. Chen has received research support from Healey Center at Massachusetts General Hospital. The institution of Dr. Chen has received research support from General Hospital Corporation. The institution of Dr. Chen has received research support from Argenx.
Marc Debouverie, MD Dr. Debouverie has nothing to disclose.
Konner Hamous No disclosure on file
Aamir Hussain, MD No disclosure on file
Hyun-Jung Jung, MD No disclosure on file
Abdul Malik, MD, FAAN No disclosure on file
H. C. Diener, MD, FAAN Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Marjorie Bunch, MD Dr. Bunch has a non-compensated relationship as a Professional Advisory Committee with Epilepsy Foundation that is relevant to AAN interests or activities.
Sailaja Enduri, MD No disclosure on file
Byung-Jo Kim No disclosure on file
Joo Y. Kwon, MD No disclosure on file
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Antoaneta J. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen.
Jean M. Bidlack, PhD No disclosure on file
Jana Godau, MD No disclosure on file
Nereo Bresolin, DR No disclosure on file
Elizabeth R. Fagan, MBBS No disclosure on file
Andrew S. Blum, MD, PhD, FAAN The institution of Dr. Blum has received research support from DOD-Ocean State Research Institute, Inc/NIH. The institution of Dr. Blum has received research support from NSF - SBIR. The institution of Dr. Blum has received research support from Alpert Medical School. The institution of Dr. Blum has received research support from Alpert Medical School. Dr. Blum has received publishing royalties from a publication relating to health care. Dr. Blum has received personal compensation in the range of $500-$4,999 for serving as a Medical Director for Ambulatory Video-EEG LTM services, on behalf of Brown Neurology with United Sleep Diagnostics.
Paola Fortis No disclosure on file
Atul Kalanuria, MD Dr. Kalanuria has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for American Medical Experts. Dr. Kalanuria has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expertiq.
Scott McGinnis, MD Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Omar A. Khan, MD, PhD No disclosure on file
Christian Denier No disclosure on file
James L. Frey, MD, FAAN No disclosure on file
Susanne Grafe, MD No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN Dr. Kornitzer has nothing to disclose.
Stephen N. Scelsa, MD No disclosure on file
Patricio Soares-da-Silva Patricio Soares-da-Silva has received personal compensation for serving as an employee of Bial - Portela & Cª S.A.. Patricio Soares-da-Silva has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Bial - Portela & Cª S.A..
David Bradley, MD Dr. Bradley has nothing to disclose.
Joanna A. Cooper, MD No disclosure on file
Valeria Drago, MD No disclosure on file
Angela Marsili Angela Marsili has nothing to disclose.
Fatema J. Serajee, MBBS Dr. Serajee has nothing to disclose.
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Frank Skidmore, MD No disclosure on file
Edward B. Bromfield, MD, FAAN No disclosure on file
Steve Chung, MD, FAAN The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Faisal Fecto, MD, PhD The institution of Dr. Fecto has received research support from NINDS.
Joseph Hentz No disclosure on file
Burk Jubelt, MD No disclosure on file
George H. Kraft, MD No disclosure on file
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
Jean-Pierre Bouchard, MD, FAAN No disclosure on file
Bruno Brochet, MD, FEAN Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Didier Ferriby, MD No disclosure on file
Mithri R. Junna, MD Dr. Junna has nothing to disclose.
Cynthia L. Comella, MD, FAAN Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Ajit K. Roy, MD No disclosure on file
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
William O. Tatum IV, DO, FAAN Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Fusun Alehan, MD No disclosure on file
Frederic Blanc No disclosure on file
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
James D. Bowen, MD Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Gregory L. Holmes, MD No disclosure on file
Nancy Slocumb No disclosure on file
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
Mark S. Quigg, MD Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
Donna Broshek Donna Broshek has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Sports Neuropsychology Society.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Jenna B. Dionisio No disclosure on file
Aaron Ellenbogen, DO Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
George J. Hutton, MD, FAAN Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Clete A. Kushida, MD, PhD Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Zachary Simmons, MD, FAAN Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Raffaella Migliaccio Raffaella Migliaccio has nothing to disclose.
Murray Engel, MD, FAAN No disclosure on file
Barry Kosofsky, MD No disclosure on file
Nancy L. Kuntz, MD, FAAN Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Max R. Lowden, MD, FAAN Dr. Lowden has nothing to disclose.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Jean C. Ouallet Jean C. Ouallet has nothing to disclose.
Gunjan Parikh, MD The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Jason R. Cornelius, MD No disclosure on file
Frank G. Gilliam, MD, MPH No disclosure on file
David King-Stephens, MD Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Jacinda B. Sampson, MD, PhD Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Aleksandar Videnovic, MD, MSc, FAAN Dr. Videnovic has nothing to disclose.
Annette Wundes, MD, FAAN The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Massimo Corbo No disclosure on file
William Dillon, MD No disclosure on file
Miya Asato, MD, FAAN Dr. Asato has nothing to disclose.
William J. Burke, MD, PhD, FAAN No disclosure on file
Juan J. Figueroa, MD No disclosure on file
Arnaud Lacour No disclosure on file
Amer Alshekhlee, MD No disclosure on file
Bashir S. Shihabuddin, MD No disclosure on file
Joyce A. Cramer No disclosure on file
John O. Fleming, MD No disclosure on file
Victoria Gonzalez, MD No disclosure on file
Neeraj Jain, MD No disclosure on file
Vincenzo Palma No disclosure on file
Carlo Rinaldi, MD, PhD No disclosure on file
Didier Deffond No disclosure on file
Mohammad Ikram The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Steven R. Schwid, MD, FAAN No disclosure on file
Patricio S. Espinosa, MD, MPH, FAAN Dr. Espinosa has nothing to disclose.
Andrei V. Alexandrov, MD The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Luigi Ferini-Strambi, MD Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Ferini-Strambi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for idorsia. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bruno Farmaceutici. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Sleep Medicine.
Anne Foundas, MD, FAAN No disclosure on file
David Gloss, MD, FAAN Dr. Gloss has received personal compensation in the range of $500-$4,999 for serving as a DUR Board Member with WV Dept of Health and Human Services.
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
Clement Hamani No disclosure on file
Jyoti Pillai, MD, MBBS, MRCP, FAAN, FAAN Dr. Pillai has a non-compensated relationship as a President with Pennsylvania Neurological Association that is relevant to AAN interests or activities.
J S. Poceta, MD No disclosure on file
Peggy Auinger Ms. Auinger has nothing to disclose.
Stefano F. Cappa, MD Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier. The institution of Dr. Cappa has received research support from Italian Minsitry of Health.
Saleh Al Deeb, MD No disclosure on file
Hiroshi Mitsumoto, MD, FAAN Dr. Mitsumoto has nothing to disclose.
Ki H. Cho, MD, PhD No disclosure on file
Daniel L. Labovitz, MD An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Daniel J. MacGowan, MD, FAAN No disclosure on file
Shima Mehrabian No disclosure on file
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
David Eidelberg, MD, FAAN Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
Giuliano Binetti, MD No disclosure on file
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Benito P. Damasceno, MD, PhD No disclosure on file
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
David C. Tong, MD, FAHA No disclosure on file
Michael Silber, MB, ChB, FAAN Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
David Arkadir, MD No disclosure on file
Michael P. Alexander, MD, FAAN No disclosure on file
Pierre Clavelou, MD, PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Luca Durelli, MD No disclosure on file
Vanessa Marques No disclosure on file
David G. Munoz, MD No disclosure on file
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
William Birmingham No disclosure on file
Daniel M. Canafax, PharmD No disclosure on file
Pamela Doty, PhD No disclosure on file
Joseph M. Ferrara, MD, FAAN No disclosure on file
Felix Fluri, MD No disclosure on file
Pierre Lozeron No disclosure on file
Silvia Messina No disclosure on file
Tai-Seung Nam, MD No disclosure on file
Wayne A. Hening, MD, PhD No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Tariq B. Alfahad, MD No disclosure on file
Donna C. Bergen, MD, FAAN No disclosure on file
Matthew P. Bussa, MPH No disclosure on file
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Izad-Yar D. Rasheed, MD Dr. Rasheed has nothing to disclose.
Luiz E. Betting Dr. Betting has nothing to disclose.
William Camu, MD No disclosure on file
Kirk R. Daffner, MD, FAAN The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Victoria S. Pelak, MD, FAAN Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.
Hyemi Chong No disclosure on file
Christina Hill-Zabala, PharmD No disclosure on file
Farrukh S. Khan, MD, MBBS No disclosure on file
Georgios Tsivgoulis, MD, FAAN Dr. Tsivgoulis has nothing to disclose.
Hardik Amin, MD No disclosure on file
Annette M. Langer-Gould, MD, PhD An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Saeed A. Bohlega, MD No disclosure on file
Violaine Plante-Bordeneuve, MD Dr. Plante-Bordeneuve has nothing to disclose.
Ronald G. Riechers II, MD No disclosure on file
Lucien Rumbach, MD No disclosure on file
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Mohamed Teleb, MD Dr. Teleb has nothing to disclose.
Rafael G. Blesa, MD Dr. Blesa has nothing to disclose.
Revere P. Kinkel, MD, FAAN Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Naila Makhani, MD Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Mohammad A. Al-Muhaizea, MD Dr. Al-Muhaizea has nothing to disclose.
Nicola De Stefano, MD Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Vincenzo Brescia Morra, MD Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Stuart D. Cook, MD, FAAN No disclosure on file
Alessandro Filla, MD, FAAN No disclosure on file
Judith Haas, MD No disclosure on file
Anhar Hassan, MBBCH, FRACP, FRCPI, FAAN The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Ahm M. Huq, MBBS, PhD Dr. Huq has nothing to disclose.
David Laplaud No disclosure on file
Laure Michel No disclosure on file
Paolo A. Muraro, MD, PhD No disclosure on file
Mario Quarantelli, MD No disclosure on file
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Pietro Tonali, MD No disclosure on file
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Fernando Acosta, MD No disclosure on file
Gail L. Risse, PhD No disclosure on file
Claudio Solaro, MD No disclosure on file
Carine Chassain, PhD No disclosure on file
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
P. D. Charles, MD, FAAN Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Jojy V. Cheriyan, MD No disclosure on file
Barbara A. Dworetzky, MD, FAAN Dr. Dworetzky has received publishing royalties from a publication relating to health care.
Stefan Gutwinski No disclosure on file
Ralf Kohnen, PhD, ScD No disclosure on file
Lahar R. Mehta, MD Dr. Mehta has received personal compensation for serving as an employee of Amylyx Pharmaceuticals.
Vijay K. Sharma, MD No disclosure on file
Mariann M. Ward, NP, MS No disclosure on file
Mario Zappia, MD No disclosure on file
W. C. LaFrance, Jr., MD, MPH, FAAN Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Jeffrey W. Britton, MD, FAAN Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Alice Chen-Plotkin, MD Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Kyoung-Gyu Choi No disclosure on file
Joanne Festa, PhD No disclosure on file
Christopher M. Filley, MD, FAAN Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Salvatore Lo Fermo No disclosure on file
Yuen T. So, MD, PhD, FAAN No disclosure on file
Virend Somers Virend Somers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Virend Somers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axome. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ApniMed. The institution of Virend Somers has received research support from National Institutes Health.
Jinsy Andrews, MD, FAAN Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
Fen Bao Fen Bao has nothing to disclose.
Andrew D. Barreto, MD No disclosure on file
Lana Boursoulian, MD No disclosure on file
Sungho K. Cho, MD Dr. Cho has nothing to disclose.
Gilles Defer, MD Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Myeong-Kyu Kim No disclosure on file
Charles M. Lourenco, MD, PhD No disclosure on file
Man Seok Park, MD, PhD No disclosure on file
Robert J. Schwartzman, MD No disclosure on file
Donald Stuss No disclosure on file
Jane Tiller No disclosure on file
Soo Y. You, MD No disclosure on file
Valerie Jaillon Riviere, MD No disclosure on file
Elias Abou-Zeid, MD No disclosure on file
Dan Bell No disclosure on file
David J. Libon, PhD No disclosure on file
Lisa R. Merlin, MD, FAAN Dr. Merlin has nothing to disclose.
Ningshan Wang, MD, PhD Dr. Wang has nothing to disclose.
Richard P. Allen, PhD No disclosure on file
Hans D. Katzberg, MD, FAAN An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Muhammad Qureshi, MD No disclosure on file
Paolo Tanganelli No disclosure on file
Frederic Taithe No disclosure on file
Latchezar D. Traykov, MD No disclosure on file
Mark Versavel, MD, PhD An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
Eric Brahin, MD No disclosure on file
Seongmin Choi, MD No disclosure on file
Alla Borisovna Guekht, PhD The institution of Prof. Guekht has received research support from Russian Science Foundation .
Naim I. Haddad, MD, FAAN Dr. Haddad has nothing to disclose.
Wilson Marques, Jr., MD Dr. Marques has nothing to disclose.
B. L. Peterlin, DO Dr. Peterlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
James M. Youakim, MD Dr. Youakim has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Youakim has stock in Acadia Pharmaceuticals.
Emanuele D'Amico Emanuele D'Amico has nothing to disclose.
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Jai Perumal, MD Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for T G therapeutics. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Jisoo S. Shin, MD No disclosure on file
Wenbo Zhang, MD, PhD No disclosure on file
Kristen Babinski, MD Dr. Babinski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Babinski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer, P.C..
Laurie Bliss No disclosure on file
Alain Creange Alain Creange has nothing to disclose.
Meghna Mansukhani No disclosure on file
Kee Duk Park, MD No disclosure on file
Amilton A. Barreira, MD No disclosure on file
A. M. Barrett, MD, FAAN The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Deanna Dickens, MD No disclosure on file
Byeong-chae Kim, MD, PhD No disclosure on file
Alexandros C. Tselis, MD, PhD No disclosure on file
Lorne H. Zinman, MD Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Michael McDermott No disclosure on file
Cristina Moglia Cristina Moglia has nothing to disclose.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Arunkumar B. Shah, MD, DM No disclosure on file
Richard Walsh, MD Dr. Walsh has nothing to disclose.
Eric M. Wassermann, MD No disclosure on file
Isa A. Al-Sharoqi, MD, MRCP No disclosure on file
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Brenda L. Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Michael Carrithers, MD, PhD The institution of Dr. Carrithers has received research support from Biogen.
Ana Laura Cif, MD No disclosure on file
Mickael Cohen No disclosure on file
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Kenneth D. Laxer, MD, FAAN Dr. Laxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Lfe Sciences. Dr. Laxer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Aurelio Mendez-Dominguez, MD Dr. Mendez-Dominguez has nothing to disclose.
Nirav Sanghani, MBBS Dr. Sanghani has nothing to disclose.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Wilmer Hale Cutler Pickering. Dr. Steinman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Daniel D. Truong, MD, FAAN The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Brian S. Tseng, MD, PhD No disclosure on file
Tzu-Ching Wu, MD Dr. Wu has nothing to disclose.
Sandrine Wiertlewski No disclosure on file
Agnes Jani-Acsadi, MD No disclosure on file
Jong W. Lee, MD, PhD The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Melanie McNally, MD No disclosure on file
Njide Okubadejo, MD, FAAN The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Joanne Quan, MD No disclosure on file
Gabriele Siciliano Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Peter J. Koudstaal, MD No disclosure on file
Edward F. Chang, MD No disclosure on file
Giuseppe De Michele, MD No disclosure on file
Sandra Donkervoort Ms. Donkervoort has nothing to disclose.
Hideki Garren, MD, PhD Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.
Douglas R. Labar, MD, PhD No disclosure on file
Fiona M. Molloy, MD Dr. Molloy has nothing to disclose.
Leo Wolansky, MD The institution of Dr. Wolansky has received research support from Guerbet.
Byung-Ok Choi, MD, PhD No disclosure on file
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Onofre Combarros Pascual No disclosure on file
Daniel Alcolea Rodriguez Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nutricia. The institution of Daniel Alcolea Rodriguez has received research support from Fujirebio - Europe. Daniel Alcolea Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Manuela De Stefano No disclosure on file
Daria Dinacci No disclosure on file
JaNean Engelstad JaNean Engelstad has nothing to disclose.
Maria Teresa Gomez-Isla, MD No disclosure on file
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
W. Michael Panneton, PhD No disclosure on file
Jack C. Rose, MD No disclosure on file
Elayna Rubens, MD No disclosure on file
Sara El Alaoui No disclosure on file
Jaime F. Godoy, MD No disclosure on file
Khatuna Gurgenashvili, MD, FAAN Dr. Gurgenashvili has nothing to disclose.
Michael J. Painter, MD, FAAN No disclosure on file
Tamara Scott No disclosure on file
Stephanie Syc-Mazurek, MD, PhD Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Arthur S. Walters, MD, FAAN No disclosure on file
Mya C. Schiess, MD, FAAN Dr. Schiess has nothing to disclose.
John Shoffner IV, MD No disclosure on file
Myriam Srour, MD, PhD Dr. Srour has nothing to disclose.
Toshiki Takenouchi, MD No disclosure on file
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Jon Infante Ceberio No disclosure on file
Randi Hagerman Randi Hagerman has received publishing royalties from a publication relating to health care.
Teepu Siddique, MD, FAAN No disclosure on file
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Philippe Coubes, PhD No disclosure on file
Siobhan Hutchinson, MD Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Padmaja N. Kandula, MD Dr. Kandula has nothing to disclose.
Dimitrios Kapogiannis, MD The institution of Dr. Kapogiannis has received research support from National Institute on Aging (NIA/NIH).
David M. Labiner, MD The institution of Dr. Labiner has received research support from CDC.
Christopher C. Luzzio, MD No disclosure on file
Augusto A. Miravalle, MD, FAAN Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Christian Otoul No disclosure on file
Patricia E. Penovich, MD, FAAN Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to AAN interests or activities.
James Rubenstein No disclosure on file
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Jan L. De Bleecker, MD, PhD, FAAN Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Daniela Galimberti, PhD No disclosure on file
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Vijay B. Kumar No disclosure on file
Netta Levin, MD, PhD Dr. Levin has nothing to disclose.
Elisabeth Simard-Tremblay, MD No disclosure on file
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Ronald B. Ziman, MD, FACP, FAAN No disclosure on file
Luisa Alves No disclosure on file
Paulo Bugalho No disclosure on file
Keith Hyland, PhD No disclosure on file
Anahid Kabasakalian, MD No disclosure on file
Andres M. Lozano, MD Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Gail H. Marracci, PhD No disclosure on file
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Brandy R. Matthews, MD, FAAN No disclosure on file
Bernard Brais, MD Dr. Brais has nothing to disclose.
Franck Durif, MD, PhD No disclosure on file
Richelle A. Hemendinger, PhD No disclosure on file
Victoria Lawson, MD, FAAN Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Eloy Rodriguez-Rodriguez Eloy Rodriguez-Rodriguez has nothing to disclose.
Florent Richy, PhD No disclosure on file
Laura Molina Porcel, MD No disclosure on file
Byung-kun Kim, MD Dr. Kim has nothing to disclose.
Li M. Li, MD No disclosure on file
Yilong Ma, PhD The institution of Dr. Ma has received research support from AskBio. The institution of Dr. Ma has received research support from Aspen Neuroscience . The institution of Dr. Ma has received research support from Blue Rock . The institution of Dr. Ma has received research support from Bayer.
Kristen Fowler No disclosure on file
Carlos A. Guerreiro, MD, FAAN No disclosure on file
David A. Hinkle, MD, PhD No disclosure on file
Samuel F. Hunter, MD, PhD The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Ja-Seong Koo, MD No disclosure on file
Chikkathur N. Madhavarao, PhD No disclosure on file
Raoul Morales, MD No disclosure on file
Marcia E. Morita-Sherman, MD An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Christianne N. Heck, MD Dr. Heck has nothing to disclose.
Nam Hee Kim, MD No disclosure on file
Ohyun Kwon No disclosure on file
Samuel J. Maiser, MD Dr. Maiser has nothing to disclose.
John M. Olichney, MD No disclosure on file
Judith L. Ross, MD No disclosure on file
Elio A. Scarpini, MD No disclosure on file
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Daniel Kantor, MD, FAAN Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities.
Flavia Mattioli, MD Dr. Mattioli has nothing to disclose.
Garth Nicholson, PhD No disclosure on file
Kathleen Poston, MD, FAAN Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Marvin A. Rossi, MD, PhD Dr. Rossi has nothing to disclose.
Robert Schmouder No disclosure on file
Jeffrey A. Switzer, DO, FAAN Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Expert Speaker on a panel with Genentech. Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with SAA Alumni Association.
Sandra L. Helmers, MD, FAAN No disclosure on file
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
J. Douglas Miles, MD, PhD, FAAN Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Irene J. Oh, MD No disclosure on file
Robbie Buechler, MD, PhD No disclosure on file
Ugo Nocentini No disclosure on file
Lynne Shinto, ND No disclosure on file
Helen E. Stephens No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union.
Frances E. Jensen, MD, FAAN Dr. Jensen has received research support from Passages Bio.
Constantine Lyketsos Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Jean Mathieu, MD Dr. Mathieu has nothing to disclose.
Elena Moro, MD, FAAN Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Paola Pergami, MD, PhD No disclosure on file
Andrea L. Rosso, MPH No disclosure on file
Kevin R. Scott, MD, FAAN No disclosure on file
Juliana Setyawan, PharmD, MS No disclosure on file
Eric Tsang No disclosure on file
Martina Vendrame, MD PhD Dr. Vendrame has nothing to disclose.
Jose Ignacio Mateo Fernandez No disclosure on file
Florian Hatz, MD No disclosure on file
Claudio Mariani, MD No disclosure on file
Meghan Jeffres No disclosure on file
Claudia V. Maurer-Morelli, PhD No disclosure on file
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Glenn E. Smith, MD, PhD No disclosure on file
Guido Schwegler, MD No disclosure on file
Philippe A. Lyrer, MD No disclosure on file
Heinrich P. Mattle, MD No disclosure on file
Letizia Mazzini No disclosure on file
Jane S. Paulsen, PhD Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Samuel J. Potolicchio, Jr., MD No disclosure on file
Perry K. Richardson, MD Dr. Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedForce.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Warren Marks, MD No disclosure on file
Michael S. Oh, MD No disclosure on file
Harry O. Openshaw, MD No disclosure on file
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Jose Luis Rodriguez-Valdez, PhD No disclosure on file
G. David Rudd, PharmD, MS No disclosure on file
Lynn Stazzone, RN Ms. Stazzone has nothing to disclose.
Claudia Trenkwalder, MD Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
Eric H. Kossoff, MD Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia. Dr. Kossoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simply Good Foods. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cambrooke. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care.
Gyula Acsadi, MD, FAAN Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ronald Barrett No disclosure on file
Sun-Ah Choi, MD, PhD No disclosure on file
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Sinead Jordan Sinead Jordan has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Idec.
Jeffrey C. Looi, MD No disclosure on file
Martijn Muller, PhD No disclosure on file
Jeffrey Mock II, PhD No disclosure on file
Bill Nikolov No disclosure on file
Maja Tippmann-Peikert, MD Dr. Tippmann-Peikert has nothing to disclose.
Bruce N. Mayes, MD No disclosure on file
Alexandros L. Georgiadis, MD No disclosure on file
Heli Hunter, NP No disclosure on file
Sucjoo Kim, MD No disclosure on file
Jung-Ju Lee, MD, PhD No disclosure on file
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Marc Narayansingh, MD No disclosure on file
Mark Guttman, MD No disclosure on file
Chunfeng Liu No disclosure on file
Mary Scaduto No disclosure on file
Sarah Smithson No disclosure on file
Chris Tang, MD No disclosure on file
Jong-Moo Park, MD No disclosure on file
Marie-Josee Dicaire Marie-Josee Dicaire has nothing to disclose.
Howard Fillit, MD No disclosure on file
Lauren Hyland No disclosure on file
Ingrid L. Kwee, MD Dr. Kwee has nothing to disclose.
A T. Perkins, MD, PhD No disclosure on file
Vijayshree Yadav, MD, FAAN Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Daniel Lee, MD, FAAN No disclosure on file
Tsutomu Nakada, MD, PhD No disclosure on file
Gregory D. Cascino, MD, FAAN Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Debabrata Ghosh, MD No disclosure on file
Patricia R. Grossman No disclosure on file
Michael I. Shevell, MD, FAAN Dr. Shevell has nothing to disclose.
Delia M. Talos, MD No disclosure on file
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Isabelle Thiffault, PhD No disclosure on file
Alberto Lleo, MD Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Lleo has received research support from Instituto de Salud Carlos III. The institution of Dr. Lleo has received research support from Generalitat de Calalunya (PERIS). The institution of Dr. Lleo has received research support from BBVA Foundation. The institution of Dr. Lleo has received research support from La Caixa Foundation. Dr. Lleo has received intellectual property interests from a discovery or technology relating to health care.
Matthias Maschke, MD No disclosure on file
Diego Garcia-Borreguero, MD No disclosure on file
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Patricia Maciel, MD No disclosure on file
Laura A. Kalayjian, MD The institution of Dr. Kalayjian has received research support from NIH.
Dheeraj Khurana, MD Dr. Khurana has nothing to disclose.
Lola C. Morgan, MD Dr. Morgan has nothing to disclose.
Mark Obermann, MD, FAAN No disclosure on file
Pedro S. Oliveira, MD No disclosure on file
Barbara E. Tettenborn, MD No disclosure on file
Gianna Carla Riccitelli No disclosure on file
Michael A. Stein, MD No disclosure on file
Felix A. Mueller, MD No disclosure on file
David Hess, MD No disclosure on file
Hans-Joerg Hungerbuehler, MD No disclosure on file
Debomoy K. Lahiri, PhD No disclosure on file
Patrik L. Michel, MD The institution of Dr. Michel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Michel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. The institution of Dr. Michel has received research support from Swiss National Science Foundation; Swiss Heart Foundation.
Jennifer R. Molano, MD, FAAN Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Patricio F. Reyes, MD, FAAN No disclosure on file
David P. Roeltgen, MD, FAAN No disclosure on file
William E. Rosenfeld, MD, FAAN The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Philippe Temperli, MD No disclosure on file
Ya-Ping Yang No disclosure on file
Elias M. Ntsoane, MD No disclosure on file
Ji-Young Park, MD No disclosure on file
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Sarah Benisty, MD No disclosure on file
Charles A. Szabo, MD, FAAN Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Jamie Pak, BA No disclosure on file
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Michael C. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Lifesciences. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SK Lifesciences .
Eppie Yiu, MD The institution of Dr. Yiu has received research support from Biogen. The institution of Dr. Yiu has received research support from Roche . The institution of Dr. Yiu has received research support from PTC. The institution of Dr. Yiu has received research support from Pfizer .
Monique M. Ryan, MD Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen . The institution of Dr. Ryan has received research support from Save our Sons Muscular Dystrophy . The institution of Dr. Ryan has received research support from Muscular Dystrophy Australia. Dr. Ryan has received publishing royalties from a publication relating to health care.
Fouzia Siddiqui, MD, FAAN No disclosure on file
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Wissam G. Deeb, MD Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to AAN interests or activities.
Maria E. Baldwin, MD Dr. Baldwin has nothing to disclose.
Dominick J. McCabe, MD, PhD No disclosure on file
Ana M. Malmierca, MD No disclosure on file
Eugene Redmond, MD No disclosure on file
Thamer S. Alkhairallah, MD, MBBS No disclosure on file
Eric Leguern, Sr., MD, PhD No disclosure on file
Patricio Chrem Mendez, MD Dr. Chrem Mendez has nothing to disclose.
Santiago Bestoso, MD No disclosure on file
Niravkumar Barot, MD Dr. Barot has nothing to disclose.
Fahad S. Al-Ajlan, MD Dr. Al-Ajlan has nothing to disclose.
Ainie Soetanto, MD No disclosure on file
Nancy Ann Oberheim Bush, MD, PhD Dr. Oberheim Bush has nothing to disclose.
Ahmad Abulaban, MD, FAAN Dr. Abulaban has nothing to disclose.
Timothy F. Cloughesy, MD Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vida Ventures. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lista Therapeutics. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stemline. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sonalasense. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jubilant. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gan & Lee. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainstorm. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Cloughesy has received personal compensation in the range of $0-$499 for serving as a Consultant for Inovio. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DNATrix. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tyme. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kintara. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Katmai. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Break Through Cancer. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kintara. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Katmai. Dr. Cloughesy has stock in Katmai. Dr. Cloughesy has stock in Chimerix. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care.
Patricia G. Barbalho, PhD No disclosure on file
Luisa Vuolo No disclosure on file
Pawel Tacik, MD The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, Anavex Life Sciences Corp. The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, AbbVie Germany, Boston Scientific Medical Technology, Medtronic. Dr. Tacik has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Merz Therapeutics, Ipsen Pharma.
Reversa R. Mills-Joseph, MD Dr. Mills has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin, Inc. Dr. Mills has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Mi Sun Oh No disclosure on file
Laxmi P. Dhakal, MD No disclosure on file
Anthony Behin No disclosure on file
Leendert H. Visser, MD No disclosure on file
Roberto Erro No disclosure on file
Jahir Miranda Acuña No disclosure on file
Vladimir Evilevitch No disclosure on file
Imen Kacem, MD Dr. Kacem has nothing to disclose.
Tiffany K. Grider, MS, CGC Ms. Grider has received personal compensation in the range of $0-$499 for serving as a author of educational material with Muscle Dystrophy Association.
Stephan Goedee, MD No disclosure on file
Paola Perini No disclosure on file
Sandeep Dhanyamraju, MD No disclosure on file
Victor H. Gonzalez-Montoya, MD No disclosure on file
Zhi-Jian Chen, MD Dr. Chen has nothing to disclose.
Marina B. Rubin, MD No disclosure on file
Valerie Rundle-Gonzalez, MD No disclosure on file
Shihui Xing, MD, PhD No disclosure on file
Janice M. Redmond, MD Dr. Redmond has nothing to disclose.
Douglas M. Turnbull No disclosure on file
Alfonso Alejandra No disclosure on file
Ersin Tan, MD Dr. Tan has nothing to disclose.
Anuschka Grobelny No disclosure on file
Eugenia Marzo No disclosure on file
Peter B. Forgacs, MD Dr. Forgacs has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Forgacs has or had stock in Xenon Pharmaneuticals.
Franziska Di Pauli Franziska Di Pauli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for horizon. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Franziska Di Pauli has received research support from Roche.
Brion D. Reichler, MD No disclosure on file
Louisa Kalsner, MD No disclosure on file
Bryan Smith, MD Dr. Smith has nothing to disclose.
Mirjam Korporal-Kuhnke, MD Dr. Korporal-Kuhnke has nothing to disclose.
David A. Cottrell, MD, PhD No disclosure on file
Janice M. Buelow, PhD, RN No disclosure on file
Priya Dhawan, MD Dr. Dhawan has nothing to disclose.
Jonathan Y. Streifler, MD No disclosure on file
John B. Falconer, MD No disclosure on file
Eric Lancaster, MD, PhD Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Joseph D. Burns, MD Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jeffery Gunter The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Venkata S. Dandamudi, MD No disclosure on file
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
Sung-Min Cho, DO Dr. Cho has nothing to disclose.
Jean Levi Ribeiro De Paiva No disclosure on file
Ben Schmand, PhD Dr. Schmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Philips. Dr. Schmand has received publishing royalties from a publication relating to health care.
Leslie Guthery Leslie Guthery has nothing to disclose.
Jennifer M. Martinez-Thompson, MD, FAAN Dr. Martinez-Thompson has nothing to disclose.
Yara Mikhaeil-Demo, MD Dr. Mikhaeil-Demo has nothing to disclose.
Egon Stenager, MD No disclosure on file
Christina Wilson, MD, FAAN Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH Stroke Net. The institution of an immediate family member of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Bristol-Myers Squibb and BMS-Pfizer/Roche Diagnostics . An immediate family member of Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care.
Mohamad Ezzeldin, MD Dr. Ezzeldin has nothing to disclose.
Lauren M. Massimo, PhD No disclosure on file
Fawad Yousuf, MBBS Dr. Yousuf has nothing to disclose.
Bharatendu Chandra, MD Dr. Chandra has received intellectual property interests from a discovery or technology relating to health care.
Mario Habek, MD Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Naila Alakbarova, MD No disclosure on file
Yi Shiau Ng No disclosure on file
Kim Yen Thi Vu, LMSW No disclosure on file
Amanda Jagolino-Cole, MD, FAAN Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 - Neurology Clinical Practice Journal. .
Judy H. Ch'ang, MD Dr. Ch'ang has nothing to disclose.
Melvin Berger, MD, PhD No disclosure on file
Thais Armangue, MD Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Alex Hillyer No disclosure on file
Iva Stankovic Iva Stankovic has nothing to disclose.
Bernard P. Chan, MD The institution of Dr. Chan has received research support from National University Hospital, Singapore.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Rezvan Rostami, MD No disclosure on file
Ali Saeed, MD No disclosure on file
Alessandra Protti No disclosure on file
Noa Bregman Noa Bregman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. The institution of Noa Bregman has received research support from Ionis pharmaceuticals.
Brandi L. Vollmer, MPH Ms. Vollmer has nothing to disclose.
Julian C. Duda, MD No disclosure on file
Kelianne Cummings No disclosure on file
Gloria Dalla Costa No disclosure on file
Sirwan K. Darweesh, MD, PhD No disclosure on file
Fiona Thomas No disclosure on file
Ximena Gamboa, MD Dr. Gamboa has nothing to disclose.
Andreas Dammann Andersen No disclosure on file
Purwa Joshi, MBBS No disclosure on file
Rens Hanewinckel, MD, PhD No disclosure on file
Stefan Sillau Stefan Sillau has nothing to disclose.